Castle Biosciences Inc — movimiento trimestral de fondos (NASDAQ:CSTL) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Activos totales 531.24 M501.71 M544.73 M562.79 M578.56 M Total de pasivos 75.4 M61.41 M89.35 M95.74 M107.68 M Capital total 455.83 M440.31 M455.38 M467.05 M470.87 M Total de pasivos y patrimonio neto 531.24 M501.71 M544.73 M562.79 M578.56 M Deuda total 10.12 M10.03 M10.04 M10.05 M10.16 M Deuda neta -456.43 M-450.58 M-454.01 M-479.48 M-472.12 M

Noticias

El director ejecutivo de Castle Biosciences, Maetzold, vende acciones por valor de 106.598 dólares

Castle Biosciences: Buying The Remaining DecisionDx-Melanoma Upside (NASDAQ:CSTL)

Castle Biosciences presenta datos de prueba de melanoma en reunión AAD

Castle Biosciences, Inc. (CSTL) Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study Transcript

CTMX Stock Rallies on Strong Phase I Colorectal Cancer Study Data

AstraZeneca's Imfinzi Secures Approval for Gastric Cancer in the EU

FDA Approves NVS' Cosentyx in Hidradenitis Suppurativa for Adolescents

United Therapeutics Stock Surges 32% in 6 Months: Here's Why

Beam Therapeutics Stock Surges 23% in 6 Months: What's Driving It?

JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU

Stokes Frank vende acciones de Castle Biosciences (CSTL) por valor de 192.000 dólares

Frank Stokes vende acciones de Castle Biosciences (CSTL) por $192k